文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

中欧和东欧老年人潜在不适当处方的流行情况:系统评价和综合分析,不进行荟萃分析。

Prevalence of potentially inappropriate prescribing in older adults in Central and Eastern Europe: a systematic review and synthesis without meta-analysis.

机构信息

Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Kralove, Charles University, Hradec Kralove, 500 05, Czech Republic.

Department of Geriatrics and Gerontology, First Faculty of Medicine, Charles University, Prague, 121 08, Czech Republic.

出版信息

Sci Rep. 2022 Oct 6;12(1):16774. doi: 10.1038/s41598-022-19860-8.


DOI:10.1038/s41598-022-19860-8
PMID:36202826
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9537527/
Abstract

We aimed to systematically review the prevalence of potentially inappropriate prescribing (PIP) in older adults in Central and Eastern Europe (CEE) in all care settings. We searched Embase and MEDLINE (up to June 2019) and checked the reference lists of the included studies and relevant reviews. Eligible studies used validated explicit or implicit tools to assess the PIP prevalence in older adults in CEE. All study designs were considered, except case‒control studies and case series. We assessed the risk of bias using the Joanna Briggs Institute Prevalence Critical Appraisal Tool and the certainty of evidence using the GRADE approach. Meta-analysis was inappropriate due to heterogeneity in the outcome measurements. Therefore, we used the synthesis without meta-analysis approach-summarizing effect estimates method. This review included twenty-seven studies with 139,693 participants. Most studies were cross-sectional and conducted in high-income countries. The data synthesis across 26 studies revealed the PIP prevalence: the median was 34.6%, the interquartile range was 25.9-63.2%, and the range was 6.5-95.8%. The certainty of this evidence was very low due to the risk of bias, imprecision, and inconsistency. These findings show that PIP is a prevalent issue in the CEE region. Further well-designed studies conducted across countries are needed to strengthen the existing evidence and increase the generalizability of findings.

摘要

我们旨在系统地综述中东欧(CEE)所有医疗保健环境中老年人潜在不适当处方(PIP)的流行情况。我们检索了 Embase 和 MEDLINE(截至 2019 年 6 月),并查阅了纳入研究和相关综述的参考文献列表。合格研究使用经过验证的明确或隐含工具来评估 CEE 老年人的 PIP 流行情况。除了病例对照研究和病例系列研究外,所有研究设计都被考虑在内。我们使用 Joanna Briggs 研究所流行率批判性评估工具评估偏倚风险,并使用 GRADE 方法评估证据确定性。由于结局测量存在异质性,不适合进行荟萃分析。因此,我们使用了综合而不进行荟萃分析的方法——总结效应估计方法。本综述纳入了 27 项研究,共涉及 139693 名参与者。大多数研究为横断面研究,在高收入国家进行。26 项研究的数据综合显示,PIP 的流行率为:中位数为 34.6%,四分位距为 25.9-63.2%,范围为 6.5-95.8%。由于存在偏倚、不精确和不一致,因此该证据的确定性非常低。这些发现表明,PIP 在 CEE 地区是一个普遍存在的问题。需要在各国开展更多精心设计的研究,以加强现有证据并提高研究结果的普遍性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a49/9537527/57fa265f808f/41598_2022_19860_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a49/9537527/9ebf3c762756/41598_2022_19860_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a49/9537527/81628994c91f/41598_2022_19860_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a49/9537527/57fa265f808f/41598_2022_19860_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a49/9537527/9ebf3c762756/41598_2022_19860_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a49/9537527/81628994c91f/41598_2022_19860_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a49/9537527/57fa265f808f/41598_2022_19860_Fig3_HTML.jpg

相似文献

[1]
Prevalence of potentially inappropriate prescribing in older adults in Central and Eastern Europe: a systematic review and synthesis without meta-analysis.

Sci Rep. 2022-10-6

[2]
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.

Cochrane Database Syst Rev. 2022-2-1

[3]
Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact.

J Clin Pharm Ther. 2013-4-2

[4]
Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review.

Eur J Clin Pharmacol. 2015-12

[5]
The prevalence and impact of potentially inappropriate prescribing among older persons in primary care settings: multilevel meta-analysis.

Age Ageing. 2020-7-1

[6]
Interventions to improve the appropriate use of polypharmacy for older people.

Cochrane Database Syst Rev. 2018-9-3

[7]
Interventions to Address Potentially Inappropriate Prescribing in Community-Dwelling Older Adults: A Systematic Review of Randomized Controlled Trials.

J Am Geriatr Soc. 2016-6

[8]
Potentially inappropriate prescribing (PIP) in older people and its association with socioeconomic deprivation-a systematic review and narrative synthesis.

BMC Geriatr. 2024-8-2

[9]
The effect of exposure to long working hours on stroke: A systematic review and meta-analysis from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury.

Environ Int. 2020-6-3

[10]
Potentially Inappropriate Prescribing Among Older Persons: A Meta-Analysis of Observational Studies.

Ann Fam Med. 2019-5

引用本文的文献

[1]
Attitudes, barriers, and facilitators toward tools supporting appropriate prescribing among healthcare professionals: a cross-sectional study.

Eur J Clin Pharmacol. 2025-5-31

[2]
Identification of the Potential Pharmacotherapeutic Risk in Hospitalized Geriatric Patients.

Cureus. 2025-3-30

[3]
Impact of a Multidisciplinary Approach to Polypharmacy Management in Community-Dwelling Older Adults: Insights From a Specialized Outpatient Clinic.

Aging Med (Milton). 2025-2-18

[4]
Prevalence of Potentially Inappropriate Prescribing in Older Adults in Gulf Cooperation Council Countries: A Systematic Review and Meta-Analysis.

J Epidemiol Glob Health. 2024-12

[5]
Prevalence of potentially inappropriate medications and prescription dynamics in elderly hospitalized patients in Spain.

BMC Geriatr. 2024-9-30

[6]
Potentially inappropriate prescribing in elderly patients with epilepsy at two referral hospitals in Ethiopia.

Front Med (Lausanne). 2024-8-29

[7]
Identification of seniors at risk (ISAR) score and potentially inappropriate prescribing: a retrospective cohort study.

Int J Clin Pharm. 2024-12

[8]
Potentially Inappropriate Medication Use in Primary Care in Switzerland.

JAMA Netw Open. 2024-6-3

[9]
Deprescribing potential of commonly used medications among community-dwelling older adults: insights from a pharmacist's geriatric assessment.

Sci Rep. 2024-3-14

[10]
Evaluation of medication safety assessment tools for pharmacist-led medication reviews: the Eastern European pilot project.

Front Pharmacol. 2024-2-16

本文引用的文献

[1]
Prescribing potentially inappropriate medications for the elderly according to Beers Criteria: systematic review.

Cien Saude Colet. 2021-8

[2]
A Systematic Review of Potentially Inappropriate Medications Use and Related Costs Among the Elderly.

Value Health Reg Issues. 2021-9

[3]
Prevalence of Polypharmacy, Hyperpolypharmacy and Potentially Inappropriate Medication Use in Older Adults in India: A Systematic Review and Meta-Analysis.

Front Pharmacol. 2021-5-19

[4]
Potentially inappropriate prescribing and its associations with health-related and system-related outcomes in hospitalised older adults: A systematic review and meta-analysis.

Br J Clin Pharmacol. 2021-11

[5]
Prevalence of Polypharmacy and Risks of Potentially Inappropriate Medication Use in the Older Population in a Developing Country: A Systematic Review and Meta-Analysis.

Gerontology. 2022

[6]
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.

BMJ. 2021-3-29

[7]
PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews.

BMJ. 2021-3-29

[8]
PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews.

Syst Rev. 2021-1-26

[9]
The prevalence and impact of potentially inappropriate prescribing among older persons in primary care settings: multilevel meta-analysis.

Age Ageing. 2020-7-1

[10]
Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline.

BMJ. 2020-1-16

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索